Multiple myeloma: Lenalidomide until disease progression or BMT?  What's the best approach?

Multiple myeloma: Lenalidomide until disease progression or BMT? What’s the best approach?

Multiple myeloma is a clonal disease of plasma cells that mainly affects individuals from the sixth decade of life. First-line treatment continues to evolve for patients with newly diagnosed disease. The 2009 IFM study brought interesting results that favored triple therapy with bortezomib, dexamethasone and lenalidomide (VRD) followed by autologous bone marrow transplantation (auto BMT) …

Multiple myeloma: Lenalidomide until disease progression or BMT? What’s the best approach? Read More »